Fujian Aonong Biological Technology Grouporp (SHSE:603363) Cyclically Adjusted FCF per Share: ¥-1.24 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603363 Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
34 GF Score
Price ¥2.94
GF Value ¥1.31
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Fujian Aonong Biological Technology Grouporp Cyclically Adjusted FCF per Share?

Fujian Aonong Biological Technology Grouporp SHSE:603363 +0.68% 34 Cyclically Adjusted FCF per Share is ¥-1.24 as of Mar. 2026. GuruFocus rates SHSE:603363 with a GF Score™ of 34/100 and a GF Value™ of ¥1.31 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Fujian Aonong Biological Technology Grouporp's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥-0.119. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-1.24 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-17), Fujian Aonong Biological Technology Grouporp's current stock price is ¥2.94. Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥-1.24. Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted Price-to-FCF of today is .


Fujian Aonong Biological Technology Grouporp  (SHSE:603363) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Fujian Aonong Biological Technology Grouporp Cyclically Adjusted FCF per Share Related Terms


Fujian Aonong Biological Technology Grouporp Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fujian Aonong Biological Technology Grouporp Cyclically Adjusted FCF per Share Chart

Fujian Aonong Biological Technology Grouporp Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.26

Fujian Aonong Biological Technology Grouporp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -1.31 -1.26 -1.24

SHSE:603363 vs ADM, BG, TSN: Cyclically Adjusted FCF per Share Comparison

For the Farm Products subindustry, Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fujian Aonong Biological Technology Grouporp Cyclically Adjusted Price-to-FCF vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted Price-to-FCF falls into.


SHSE:603363
34GF Score
Fujian Aonong Biological Technology Group Incorp Ltd SHSE:603363
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fujian Aonong Biological Technology Grouporp Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fujian Aonong Biological Technology Grouporp's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.119/116.3033*116.3033
=-0.119

Current CPI (Mar. 2026) = 116.3033.

Fujian Aonong Biological Technology Grouporp Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201512 0.000 100.600 0.000
201609 0.000 102.400 0.000
201612 0.000 102.600 0.000
201703 -0.261 103.200 -0.294
201706 0.207 103.100 0.234
201709 -0.365 104.100 -0.408
201712 -0.394 104.500 -0.439
201803 -0.735 105.300 -0.812
201806 0.040 104.900 0.044
201809 -0.197 106.600 -0.215
201812 -0.076 106.500 -0.083
201903 -0.019 107.700 -0.021
201906 -0.118 107.700 -0.127
201909 -0.190 109.800 -0.201
201912 -0.056 111.200 -0.059
202003 -0.498 112.300 -0.516
202006 -1.562 110.400 -1.646
202009 -1.461 111.700 -1.521
202012 -0.891 111.500 -0.929
202103 -1.509 112.662 -1.558
202106 -0.973 111.769 -1.012
202109 -0.317 112.215 -0.329
202112 -0.370 113.108 -0.380
202203 -0.393 114.335 -0.400
202206 -0.843 114.558 -0.856
202209 -0.276 115.339 -0.278
202212 0.379 115.116 0.383
202303 0.036 115.116 0.036
202306 0.005 114.558 0.005
202309 0.245 115.339 0.247
202312 0.261 114.781 0.264
202403 -0.194 115.227 -0.196
202406 0.203 114.781 0.206
202409 -0.104 115.785 -0.104
202412 -0.358 114.893 -0.362
202503 -0.160 115.116 -0.162
202506 -0.005 114.907 -0.005
202509 -0.010 115.471 -0.010
202512 0.153 115.832 0.154
202603 -0.119 116.303 -0.119

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥-1.24 mean?
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a Cyclically Adjusted FCF per Share of ¥-1.24 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors.
Is Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted FCF per Share too high?
Fujian Aonong Biological Technology Grouporp's current Cyclically Adjusted FCF per Share is ¥-1.24. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted FCF per Share compare to ADM and BG?
Fujian Aonong Biological Technology Grouporp's Cyclically Adjusted FCF per Share of ¥-1.24 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted FCF per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. Fujian Aonong Biological Technology Grouporp's current Cyclically Adjusted FCF per Share is ¥-1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.31, compared to a current price of ¥2.94 — trading 124.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥-1.24. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current Cyclically Adjusted FCF per Share is ¥-1.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?

Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued. The current stock price of ¥2.94 is trading 124.4% above its estimated GF Value™ of ¥1.31. GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.

Key valuation signals for SHSE:603363:

  • Cyclically Adjusted FCF per Share: ¥-1.24
  • GF Value™: ¥1.31 vs. price of ¥2.94 (124.4% above fair value)
  • GF Score™: 34/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fujian Aonong Biological Technology Grouporp Business Description

Address Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
34GF Score

Get the complete analysis for SHSE:603363

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.94
Price
¥1.31
GF Value